论文信息 - Bortezomib Plus Dexamethasone (VD)Versus Reduced-dose bortezomib Plus Thalidomide Plus Dexametasone (vTD) as Induction Treatment Prior to Autologous Stem-Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM) - 字舞流文

Bortezomib Plus Dexamethasone (VD)Versus Reduced-dose bortezomib Plus Thalidomide Plus Dexametasone (vTD) as Induction Treatment Prior to Autologous Stem-Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM)

J. Mary | P. Moreau | H. Avet-Loiseau | C. Mathiot | T. Facon | J. Harousseau | C. Doyen | M. Attal | L. Garderet | M. Tiab | C. Hulin | G. Lepeu | M. Petillon | Christine Aranjo | Denis Cailliot